AGP Executive Report
Last update: an hour agoFDA & Drugs: FDA extended its review of Praxis Precision Medicines’ relutrigine, pushing the PDUFA target to Dec. 27, 2026. FDA Recalls: FDA announced a new nationwide recall on a blood pressure medication (chlorthalidone), citing failed dissolution specs that could reduce effectiveness. Food Safety: CDC is tracking four active foodborne outbreaks, including a large Salmonella outbreak tied to jalapeño peppers and other illnesses linked to sprouts and pet turtles. Diabetes Care: US FDA approval news for once-weekly insulin efsitora alfa-gobe highlights new dosing and titration approaches for adults with type 2 diabetes. AI in Healthcare Costs: Blue Cross Blue Shield Association analysis says AI-assisted hospital coding added $942M to spending over 2024–2025, with insurers alleging upcoding. Community Health Fundraising: Walk/Run events for Georgetown Hospital and North Bay Regional Health Centre raised major sums for diagnostic equipment and patient care. Maternal & Emergency Systems: Vietnam plans a nationwide smart pre-hospital emergency platform in 2027 to improve dispatch and coordination. Public Health & Prevention: Experts warn excessive screen time and poor posture may contribute to children’s spine issues; separate AIIMS coverage flags traumatic dental injuries as a huge, often overlooked global burden.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.